METLIFE INC
For the period ended Dec 31, 2024. Filed Feb 21, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 21, 2025
MET$102.44+0.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
Consolidated Statements of Cash Flows
| 2024 | 2023 | 2022 | |
|---|---|---|---|
| Cash flows from operating activities | |||
| Net income (loss) | $4,444 | $1,602 | $5,302 |
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | |||
| Depreciation and amortization expenses | 714 | 718 | 673 |
| Amortization of premiums and accretion of discounts associated with investments, net | (1,512) | (1,332) | (992) |
| (Gains) losses on investments and from sales of businesses, net | 1,165 | 2,800 | 1,260 |
| (Gains) losses on derivatives, net | 2,716 | 3,259 | 4,150 |
| (Income) loss from equity method investments, net of dividends or distributions | 844 | 1,090 | 505 |
| Interest credited to policyholder account balances | 8,484 | 7,970 | 3,771 |
| Universal life and investment-type product policy fees | (4,251) | (4,031) | (3,969) |
| Change in contractholder-directed equity securities and fair value option securities | (518) | (539) | 1,671 |
| Change in accrued investment income | (18) | (194) | (357) |
| Change in premiums, reinsurance and other receivables | 460 | (1,952) | 299 |
| Change in market risk benefits | (782) | (658) | (3,347) |
| Change in deferred policy acquisition costs and value of business acquired, net | (791) | (660) | (800) |
| Change in income tax | (484) | (1,177) | 198 |
| Change in other assets | — | (124) | 138 |
| Change in insurance-related liabilities and policy-related balances | 4,079 | 4,637 | 3,937 |
| Change in other liabilities | (580) | 2,115 | 360 |
| Other, net | 628 | 197 | 245 |
| Net cash provided by (used in) operating activities | 14,598 | 13,721 | 13,044 |
| Cash flows from investing activities | |||
| Sales, maturities and repayments of: | |||
| Fixed maturity securities available-for-sale | 55,650 | 58,816 | 88,937 |
| Equity securities | 158 | 1,018 | 873 |
| Mortgage loans | 10,363 | 8,505 | 10,779 |
| Real estate and real estate joint ventures | 753 | 143 | 1,096 |
| Other limited partnership interests | 1,083 | 915 | 1,615 |
| Short-term investments | 11,841 | 13,117 | 14,094 |
| Purchases and originations of: | |||
| Fixed maturity securities available-for-sale | (65,667) | (63,460) | (82,956) |
| Equity securities | (112) | (73) | (1,368) |
| Mortgage loans | (8,950) | (8,795) | (16,403) |
| Real estate and real estate joint ventures | (1,033) | (1,057) | (1,208) |
| Other limited partnership interests | (1,401) | (1,670) | (2,674) |
| Short-term investments | (10,943) | (14,000) | (11,741) |
| Cash received in connection with freestanding derivatives | 2,288 | 3,145 | 4,524 |
| Cash paid in connection with freestanding derivatives | (3,981) | (5,662) | (7,793) |
| Sales of businesses, net of cash and cash equivalents disposed of $0, $0 and $67, respectively | — | — | 590 |
| Purchases of investments in operating joint ventures | (40) | — | (240) |
| Net change in policy loans | 106 | 34 | 104 |
| Net change in other invested assets | (1,435) | (1,079) | (786) |
| Other, net | (173) | (143) | (63) |
| Net cash provided by (used in) investing activities | $(11,493) | $(10,246) | $(2,620) |
Consolidated Statements of Cash Flows — (continued)
| 2024 | 2023 | 2022 | |
|---|---|---|---|
| Cash flows from financing activities | |||
| Policyholder account balances - deposits | $97,877 | $95,587 | $103,901 |
| Policyholder account balances - withdrawals | (94,914) | (90,876) | (98,591) |
| Net change in payables for collateral under securities loaned and other transactions | (244) | (3,283) | (10,730) |
| Long-term debt issued | 1,568 | 1,989 | 1,013 |
| Long-term debt repaid | (1,792) | (1,035) | (85) |
| Collateral financing arrangement repaid | (161) | (79) | (50) |
| Derivatives with certain financing elements and other derivative-related transactions, net | (157) | (74) | (61) |
| Proceeds from mortgage loan secured financing | 285 | 682 | — |
| Repayments of mortgage loan secured financing | (882) | (845) | — |
| Treasury stock acquired in connection with share repurchases | (3,207) | (3,103) | (3,326) |
| Dividends on preferred stock | (200) | (198) | (185) |
| Dividends on common stock | (1,527) | (1,566) | (1,598) |
| Other, net | 223 | (139) | (236) |
| Net cash provided by (used in) financing activities | (3,131) | (2,940) | (9,948) |
| Effect of change in foreign currency exchange rates on cash and cash equivalents balances | (545) | (91) | (397) |
| Change in cash and cash equivalents | (571) | 444 | 79 |
| Cash and cash equivalents, including subsidiaries held-for-sale, beginning of year | 20,639 | 20,195 | 20,116 |
| Cash and cash equivalents, including subsidiaries held-for-sale, end of year | $20,068 | $20,639 | $20,195 |
| Cash and cash equivalents, subsidiaries held-for-sale, beginning of year | $— | $— | $69 |
| Cash and cash equivalents, subsidiaries held-for-sale, end of year | $— | $— | $— |
| Cash and cash equivalents, beginning of year | $20,639 | $20,195 | $20,047 |
| Cash and cash equivalents, end of year | $20,068 | $20,639 | $20,195 |
| Supplemental disclosures of cash flow information | |||
| Net cash paid (received) for: | |||
| Interest | $1,037 | $989 | $905 |
| Income tax | $1,600 | $1,833 | $1,056 |
| Non-cash transactions: | |||
| Fixed maturity securities available-for-sale disposed of in connection with a reinsurance transaction | $— | $8,984 | $— |
| Fixed maturity securities available-for-sale received in connection with pension risk transfer transactions | $3,538 | $2,749 | $8,707 |
| Mortgage loans disposed of in connection with a reinsurance transaction | $— | $196 | $— |
| Real estate and real estate joint ventures acquired in satisfaction of debt | $359 | $32 | $495 |
| Other invested assets received in connection with the sale of other limited partnership interests | $375 | $— | $— |
| Consolidation of real estate and real estate joint ventures: | |||
| Increase of real estate and real estate joint ventures | $134 | $— | $— |
| Increase of short-term debt | $113 | $— | $— |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.